Mar 22, 2022 / 01:45PM GMT
Paul Knight - KeyBanc Capital Markets - Analyst
Good morning. This is Paul Knight, the life science and diagnostics analyst at KeyBanc. It's a pleasure to have Castle Biosciences here today. We have the CEO, Derek Maetzold; Chief Financial Officer, Frank Stokes; and Head of Investor Relations, Camilla Zuckero. We'll have a presentation by Castle. We will then open it up for some Q&A. (Conference Instructions)
So Frank, thanks for your time -- Derek, thanks for your time, and we'll let you do the overview.
Derek Maetzold - Castle Biosciences, Inc. - Founder, President, & CEO
Excellent. Thank you, Paul, and thank you to the KeyBanc team for inviting us here to participate in your 2022 Life Sciences & MedTech Investor Forum. It's a pleasure to be here. We just put together a couple of slides to kind of give the audience just a quick snapshot of who Castle Biosciences is, how we closed out 2021, and some near-term milestones and 2022 guidance, so we can set that as a table setter to go forward here.
Disclaimer slide. Our vision is to
Castle Biosciences Inc at KeyBanc Capital Markets Life Sciences & MedTech Forum (Virtual) Transcript
Mar 22, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers